10x Genomics, Inc. (TXG)

10x Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	625.45	618.73	516.41	490.49	298.85	245.89
Revenue Growth (YoY)	16.64%	19.81%	5.28%	64.13%	21.53%	68.06%
Cost of Revenue	221.61	209.41	120.39	74.09	58.47	61.03
Gross Profit	403.84	409.31	396.02	416.4	240.38	184.86
Selling, General & Admin	345.82	343.33	298.3	257.56	202.33	130.83
Research & Development	271.87	270.33	265.67	211.75	123.38	83.1
Other Operating Expenses	60.98	60.98	0	-0.66	448.82	1.5
Operating Expenses	678.68	674.64	563.97	468.65	774.52	215.43
Operating Income	-274.84	-265.33	-167.94	-52.25	-534.14	-30.57
Interest Expense / Income	0.02	0.03	0.48	0.87	1.68	3.08
Other Expense / Income	-17.94	-16.6	-6.45	0.6	-1.35	-2.62
Pretax Income	-256.91	-248.76	-161.97	-53.72	-534.48	-31.03
Income Tax	7.39	6.34	4.03	4.51	8.26	0.22
Net Income	-264.3	-255.1	-166	-58.22	-542.73	-31.25
Shares Outstanding (Basic)	119	117	114	110	101	39
Shares Outstanding (Diluted)	119	117	114	110	101	39
Shares Change	3.26%	2.90%	3.18%	9.09%	158.76%	191.89%
EPS (Basic)	-2.23	-2.18	-1.46	-0.53	-5.37	-0.80
EPS (Diluted)	-2.23	-2.18	-1.46	-0.53	-5.37	-0.80
Free Cash Flow	-73.75	-63.8	-165.27	-122.65	-254.56	-8.12
Free Cash Flow Per Share	-0.62	-0.55	-1.45	-1.11	-2.52	-0.21
Gross Margin	64.57%	66.15%	76.69%	84.89%	80.44%	75.18%
Operating Margin	-43.94%	-42.88%	-32.52%	-10.65%	-178.74%	-12.43%
Profit Margin	-42.26%	-41.23%	-32.15%	-11.87%	-181.61%	-12.71%
Free Cash Flow Margin	-11.79%	-10.31%	-32.00%	-25.01%	-85.18%	-3.30%
EBITDA	-210.4	-205.11	-128.49	-24.6	-513.77	-20.89
EBITDA Margin	-33.64%	-33.15%	-24.88%	-5.01%	-171.92%	-8.49%
Depreciation & Amortization	46.5	43.62	33.01	28.25	19.02	7.07
EBIT	-256.9	-248.73	-161.5	-52.85	-532.79	-27.95
EBIT Margin	-41.07%	-40.20%	-31.27%	-10.77%	-178.28%	-11.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).